|
BN005
|
-
|
A Phase II Trial Randomized Trial of Proton vs. Photon Therapy (IMRT) for Cognitive Preservation in Patients with IDH Mutant, Low to Intermediate Grade Gliomas. -- (Closed 03/19/2024)
|
|
BN007
|
-
|
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients with Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma - Closed on 03/29/2023
|
|
CC001
|
-
|
A Randomized Phase III Trail of Memantine And Whole-Brain Radiotherapy With or Without Hippocampal Avoidance In Patients With Brain Metastases--(Closed 5/1/2017)
|
|
CC003
|
-
|
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With Or Without Hippocampal Avoidance For Small Cell Lung Cancer -- (Closed 06/21/2022)
|
|
LU001
|
-
|
Randomized Phase II trial of Concurrent Chemoradiotherapy +/- Metformin HCL in Locally Advanced NSCLC --(Closed 12/15/2016)
|
|
LU002
|
-
|
Maintenance Systemic Therapy Versus Consolidative Stereotactic Body Radiation
Therapy (SBRT) Plus Maintenance Systemic Therapy for Limited Metastatic
Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial--
Closed on 12/06/2023
|
|
GI001
|
-
|
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
|
|
GI002
|
-
|
A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer -- Closed on (5/14/2019)
|
|
GI007
|
-
|
PHASE I TRIAL WITH EXPANSION COHORT OF OBP-301 (TELOMELYSINTM) AND DEFINITIVE CHEMORADIATION FOR PATIENTS WITH LOCALLY ADVANCED ESOPHAGEAL AND GASTROESOPHAGEAL ADENOCARCINOMA WHO ARE NOT CANDIDATES FOR SURGERY -- closed on 04/21/2023
|
|
GU001
|
-
|
Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy For pT3/pT4 Urothelial Bladder Cancer --Closed(2/2/2017)
|
|
GU003
|
-
|
A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-Prostatectomy Radiation Therapy (COPORT)
-- Closed(7/9/2018)
|
|
GY006
|
-
|
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer -- CLosed on 09/22/2022
|
|
HN001
|
-
|
Randomized Phase II and Phase III Studies of Individualized Treatment For Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
-- Closed(7/21/2023)
|
|
HN002
|
-
|
A Randomized Phase II Trial for Patients with p16 Positive, Non-Smoking Associated, Locoregionally Advanced Oropharyngeal Cancer.--Closed(2/7/2017)
|
|
HN003
|
-
|
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and Mk-3475 (PEMBROLIZUMAB) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC).
|
|
HN004
|
-
|
Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin ---- closed (9/1/2022)
|
|
HN008
|
-
|
Phase I Trial with Expansion Cohort of DNA-PK Inhibition and IMRT in Cisplatin-Ineligible Patients with Stage 3-4 Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) ---- closed (01/06/2025)
|
|
GU006
|
-
|
A PHASE II, DOUBLE-BLINDED, PLACEBO-CONTROLLED RANDOMIZED TRIAL OF SALVAGE RADIOTHERAPY WITH OR WITHOUT ENHANCED ANTI-ANDROGEN THERAPY WITH APALUTAMIDE IN RECURRENT PROSTATE CANCER
|
|
LU004
|
-
|
Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With MEDI4736 (durvalumab) in PD-L1 High Locally Advanced Non-Small Cell Lung Cancer (NSCLC) (ARCHON-1)
|
|
LU006
|
-
|
PHASE III RANDOMIZED TRIAL OF PLEURECTOMY/DECORTICATION PLUS CHEMOTHERAPY WITH OR WITHOUT ADJUVANT HEMITHORACIC INTENSITY-MODULATED PLEURAL RADIATION THERAPY (IMPRINT) FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM) -- CLosed (11/20/2023)
|
|
BR002
|
-
|
A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer--closed 5/27/22
|
|
BR001
|
-
|
A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
|
|
BN001
|
-
|
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma (closure date of May 11, 2022)
|
|
LU005
|
-
|
LIMITED STAGE SMALL CELL LUNG CANCER (LS-SCLC): A PHASE II/III RANDOMIZED STUDY OF CHEMORADIATION VERSUS CHEMORADIATION PLUS ATEZOLIZUMAB (closure date of July 1, 2022)
|